Dr. Ralph DaCosta, founder of MolecuLight Inc. (Toronto, Canada), will deliver an insightful presentation on the development of a groundbreaking optical imaging platform technology that leverages fluorescence imaging and other advanced techniques. This technology addresses globally significant clinical needs by enhancing the detection of dangerous infections in wounds and improving the identification of positive margins during breast cancer surgery. Dr. DaCosta will take the audience on a journey from the “eureka moment” of invention through the intricate process of research and development, culminating in the establishment and funding of a company dedicated to commercializing this innovation in wound care and cancer surgery applications.

The presentation will offer a candid reflection on the challenges faced, including mistakes made and lessons learned, as well as the successes achieved along the way. Dr. DaCosta will highlight the complexities of transforming a novel scientific discovery from a laboratory concept into a globally successful commercial product. He will discuss the hurdles encountered in securing funding, navigating research institutions, and dealing with investors, all of which were critical in bringing MolecuLight’s technology to market.

The objective of this presentation is to provide attendees with a deeper understanding of the challenges involved in solving pressing medical problems and the triumphs that can be realized when these challenges are overcome. Through real-world examples, Dr. DaCosta aims to inspire and inform those interested in the intersection of science, medicine, and entrepreneurship.
Bio